Glycopezil serves a novel category of antibiotic agent currently under research. It exhibits promising activity against a wide range of bacterial strains, including those resistant to existing antibiotic therapies. The process of action remains investigated, but initial findings suggest that Glycopezil affects bacterial cell wall production. Clinic